What this study is
This study evaluates whether an artificial intelligence (AI) conversational agent called MINERVA (Medical Interface for Navigating the Emergency Room with Voice Assistance) can safely and feasibly gather medical histories from emergency department (ED) patients and produce accurate summaries. The main questions it aims to answer are:
Can an AI conversational agent gather and summarize patient histories in the emergency department?
Are the resulting summaries accurate? Do they capture essential clinical information?
Can an AI agent overseeing these conversations independently identify red-flag symptoms that may need time-sensitive clinical interventions?
Adult ED patients interact with MINERVA via either voice chat or typing on a keyboard. MINERVA asks them questions about their symptoms and generates a summary which the patients review for accuracy. MINERVA reviews the conversation for clinical red flags that suggest urgent evaluation is required. Participants fill out a survey providing feedback on their experience. The summary is not saved in the medical record and clinical care is not affected.
Physician reviewers will evaluate the safety, accuracy, and clinical value of the MINERVA interview transcripts and summaries using standardized rubrics, including whether MINERVA was correct in identifying red-flag symptoms that may need time-sensitive clinical interventions.
What's being tested
- MINERVA AI Chatbot
Intervention · OTHER
The MINERVA AI chatbot is AI software that allows patients to provide medical history through text or voice.
Study details
- Official title
- Feasibility and Acceptability of a Voice Conversational Agent in the Emergency Department
- Sponsor
- Beth Israel Deaconess Medical Center
- Conditions
- History Taking · Artificial Intelligence (AI)
- Enrolling
- 250 people
- Starts
- 2026-10-01
- Est. completion
- 2027-02-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients aged ≥18 years.
- Patient underwent triage in the ED.
- English-speaking.
You can't join if
- Critical illness precluding interaction with MINERVA.
- Inability to provide consent.
- Significant hearing/speech/typing impairments precluding interaction by text or voice.
- Prisoners.
- Inability to follow study procedures.
- Patients requiring isolation precautions incompatible with study procedures.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openBeth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Study team
Sponsor
Beth Israel Deaconess Medical Center
Study ID 2025P000446
Principal investigator
Adrian Haimovich, MD, PhD
Beth Israel Deaconess Medical Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.